---
figid: PMC9023153__ECAM2022-8489699.003
pmcid: PMC9023153
image_filename: ECAM2022-8489699.003.jpg
figure_link: /pmc/articles/PMC9023153/figure/fig3/
number: Figure 3
figure_title: ''
caption: Related factors in mice serum of all groups (Δp < 0.01, comparable to the
  S group; ∗∗p < 0.01, comparable to the M group; ∗p < 0.05, comparable to the M group;
  S, sham operation group; M, model group; P, positive control group; MDFD-H, modified
  Dahuang Fuzi Decoction high-dose group; MDFD-M, modified Dahuang Fuzi Decoction
  medium-dose group; MDFD-L, modified Dahuang Fuzi Decoction low-dose group; BUN,
  blood urea nitrogen; SCr, serum creatinine; KIM-1, kidney injury factor-1; β2-MG,
  β2-microglobulin; MDA, malondialdehyde; SOD, superoxide dismutase; IL-1β, interleukin-1β;
  TNF-α, tumor necrosis factor-α).
article_title: Treatment of Modified Dahuang Fuzi Decoction on Cognitive Impairment
  Induced by Chronic Kidney Disease through Regulating AhR/NF-κB/JNK Signal Pathway.
citation: Mingjia Gu, et al. Evid Based Complement Alternat Med. 2022;2022:8489699.
year: '2022'

doi: 10.1155/2022/8489699
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
